Thomas Wellner has extensive global experience in biotech, pharmaceuticals and health care services in both public and private businesses. Prior to joining Revera in April 2014, Mr. Wellner was co-CEO of LifeLabs, and was previously President and CEO of CML HealthCare where he led the transformation of the organization by setting a new strategic direction, improving operational effectiveness and completing multiple transactions. He also served as President and CEO of Therapure Biopharma, a company specializing in contract development and manufacturing of biologics. He began his career at global pharmaceutical firm Eli Lilly and held a variety of leadership roles, including President and General Manager of operations in Germany. Mr. Wellner holds an Honours Bachelor of Science degree in Life Sciences from Queen’s University, and has completed executive education through Harvard Business School. He has been a guest lecturer on international business and healthcare at Harvard, Rotman and INSEAD Schools of Business, and has been engaged in significant advisory work within public equity and venture capital communities.